Transarterial chemoembolization combined with immunotherapy and targeted therapy as first-line treatment for unresectable and non-metastatic hepatocellular carcinoma: a meta-analysis of phase III trials

Authors

Institutions

Publication Details

Journal
Therapeutic Advances in Gastroenterology
Published
2025-11-01
DOI
https://doi.org/10.1177/17562848251396424
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transarterial chemoembolization combined with immunotherapy and targeted therapy as first-line treatment for unresectable and non-metastatic hepatocellular carcinoma: a meta-analysis of phase III trials

Jinhai Shen, Mingrui Zhao, Bo Luo, Lele Wang
Therapeutic Advances in Gastroenterology
Hepatocellular Carcinoma Treatment and Prognosis
article

Transarterial chemoembolization combined with immunotherapy and targeted therapy as first-line treatment for unresectable and non-metastatic hepatocellular carcinoma: a meta-analysis of phase III trials

Jinhai Shen, Mingrui Zhao, Bo Luo, Lele Wang
article en

Abstract

No abstract available for this paper.
Therapeutic Advances in GastroenterologyVol. 18
Hebei Medical University (CN), China Pharmaceutical University (CN), Second Hospital of Hebei Medical University (CN)
Openalex Percentile: Top 54%
Hepatocellular Carcinoma Treatment and Prognosis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.